1. Introduction {#s0005}
===============

Structural magnetic resonance imaging (MRI) biomarkers of Alzheimer\'s disease (AD) are an active research area, and a wide range of biomarkers have been proposed and investigated ([@bb0245], [@bb0075], [@bb0100]). The importance of structural MRI in AD was underlined by its inclusion in criteria for AD diagnosis ([@bb0150]). To date, the volume of the hippocampus is the most studied and used structural MRI biomarker of AD ([@bb0155]), and it is so far the only structural MRI biomarker that has been qualified for enrichment of clinical trials ([@bb0135]). Volumetry is generally a popular type of biomarker, and the region of interest (ROI) is not limited to the hippocampus. Examples of other ROIs include the amygdala ([@bb0240]), the ventricles ([@bb0280]), and the whole brain ([@bb0280]). Other types of biomarkers include cortical thickness measurements ([@bb0255], [@bb0095]), shape ([@bb0115], [@bb0005]), texture ([@bb0050], [@bb0265]), proximity of brain structures ([@bb0190]), whole brain dissimilarities computed from a deformation ([@bb0170]), and methods based on voxel-wise modulated intensities ([@bb0025], [@bb0080], [@bb0175]).

Some MRI biomarkers complement each other. For example, it has been shown that hippocampal shape and texture provide diagnostic information independent of hippocampal volume ([@bb0005], [@bb0265]). Moreover, markers applied in different parts of the brain are expected to be sensitive to different stages of the disease. For example, the hippocampus is affected early by neurofibrillary tangles, a pathological hallmark of AD, whereas the cortex is only affected later ([@bb0040]). This has been empirically reflected by hippocampal volume being better at separating normal controls (NC) and mild cognitive impairment (MCI), the prodromal stage of AD ([@bb0055]), whereas cortical thickness measurements have been shown to better separate MCI from AD ([@bb0255]). A combination of such complementary biomarkers may provide an overall better biomarker, especially when several diagnostic groups are considered (e.g., NC, MCI, AD). Accordingly, the combination of volumetry and cortical thinning has been used in several studies ([@bb0100]).

Considering the multitude of MRI biomarkers, there is a need for standardized comparisons of methods on the same dataset in order to better understand how different biomarkers perform and what their relations are. The recent release of standardized datasets for the comparison of algorithms from the Alzheimer\'s Disease Neuroimaging Initiative (ADNI) ([@bb0315]) was an important step in this direction, especially because ADNI is the most commonly used reference database in AD MRI biomarker research ([@bb0300]). Likewise, recent large empirical comparison studies ([@bb0075], [@bb0250]) and the Computer-Aided Diagnosis of Dementia (CADDementia) challenge ([@bb0045]) have been important steps.

CADDementia, hosted by the 17th International Conference on Medical Image Computing & Computer-Assisted Intervention (MICCAI), was a challenge on differential diagnosis of NC, subjects with MCI and patients suffering from AD based on a single structural MRI scan. The challenge provided an opportunity for different research groups to directly compare their methods in a completely standardized fashion. Notable characteristics of CADDementia included: •differential diagnosis of NC, MCI, and AD, i.e., considering the three-class classification problem rather than pairwise comparisons, which are often reported in the literature;•validation on a completely independent and unseen dataset from a different cohort; and•standardized validation, i.e., evaluation metrics defined, implemented, and applied by the CADDementia team.

In this study, we propose a method that combines a range of volumetric measurements, cortical thickness measurements, hippocampal texture, and hippocampal shape, to obtain a combination biomarker that used more of the information contained in a structural MRI scan compared with a single biomarker approach. The purpose is simultaneous differential diagnosis of NC, MCI, and AD. This is a unique combination of basic MRI biomarkers not used before. The combination is achieved by entering all biomarkers as features in a linear discriminant analysis (LDA) classifier. The proposed method was developed and trained on a combination of MRI scans from ADNI ([@bb0315]) and the MRI imaging arm of the Australian Imaging, Biomarker & Lifestyle Flagship Study of Aging (AIBL) ([@bb0085]). The method was evaluated using cross-validation on the combination of ADNI and AIBL data, and by participation in the CADDementia challenge. The classification accuracy (CA) and area under the receiver operating characteristic (ROC) curve (AUC) estimated using the combination of ADNI and AIBL were comparable to the performance achieved in the CADDementia challenge, and the CADDementia test set CA was the highest among the participating teams, resulting in the first place at the challenge. Our method also achieved the highest AUC in the challenge.

A preliminary version of the work presented here appeared in the CADDementia workshop proceedings ([@bb0275]). The present study contains a detailed description of the method and the obtained results. Moreover, we perform additional experiments to investigate feature relations and importance in the method, and to investigate whether more data and/or a more complex classifier would have benefited the method.

2. Material and methods {#s0010}
=======================

2.1. The CADDementia challenge {#s0015}
------------------------------

The CADDementia challenge ([@bb0045]) used data collected from three different sites, and the data were split into two datasets, a validation dataset (30 scans) that included the clinical diagnosis, and a test data set (354 scans) for which clinical diagnosis was not available to the challenge participants. Participants were encouraged to use other data sources such as ADNI for training of their methods. The CADDementia validation set was mainly supplied for participants to gauge their performance. The CADDementia test set was the data to be analyzed and scores be submitted for the challenge.

The data was made available via the CADDementia website[1](#fn0005){ref-type="fn"} on March 1, 2014, and test set scores were to be uploaded via the website no later than June 16, 2014. A total of 15 teams uploaded scores. Each team was allowed to upload 5 attempts, and a total of 29 attempts were uploaded. The results of the challenge were revealed at the challenge workshop at MICCAI on September 18, 2014.

The Python scripts used for evaluation of the results were also made available via the website, so each team could compute their performance on the validation set using the exact same code that would later be used to compute the performance on the test set.

Methods were ranked using the three-class CA (for NC, MCI, and AD), which was based on a hard classification output of the methods. Teams could supply soft classification outputs as well in order to also have ROC statistics computed. The AUC acted as secondary performance measure, i.e., ties according to CA were to be resolved using AUC.

2.2. Data {#s0020}
---------

Data used in this study were obtained from three different cohorts: ADNI, AIBL, and CADDementia. [Table 1](#t0005){ref-type="table"} provides an overview.

### 2.2.1. ADNI standardized dataset {#s0025}

We used the "complete annual year 2 visits" 1.5T dataset from the collection of standardized datasets released by ADNI ([@bb0315]). Raw unprocessed 1.5 T T1-weighted MRI images were downloaded from the ADNI database between February 1, 2012 and November 11, 2012, and the standardized dataset definition was downloaded from the ADNI website (<http://adni.loni.usc.edu/methods/mri-analysis/adni-standardized-data/>) on September 28, 2012.

The ADNI was launched in 2003 by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, the Food and Drug Administration, private pharmaceutical companies, and non-profit organizations, as a \$60 million, 5-year, public-private partnership. The primary goal of ADNI has been to test whether serial MRI, positron emission tomography (PET), biological markers, and clinical and neuropsychological assessments can be combined to measure the progression of mild cognitive impairment (MCI) and early AD. Determination of sensitive and specific markers of very early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as to lessen the time and cost of clinical trials. ADNI is the result of efforts of many co-investigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the U.S. and Canada. For up-to-date information, see [www.adni-info.org](http://www.adni-info.org){#ir0040}.

### 2.2.2. AIBL imaging arm {#s0030}

This dataset comprised the AIBL baseline imaging arm available via the ADNI database. The 3 T T1-weighted baseline structural MRI images were downloaded between September 27, 2013 and September 30, 2013. The data was collected by the AIBL study group. The AIBL study methodology has been reported previously ([@bb0085]).

### 2.2.3. ADNI HHP subset {#s0035}

This dataset comprised a subset of 40 manual hippocampus segmentations from the Harmonized Hippocampal Protocol (HHP) ([@bb0035]) as well as the associated 1.5 T ADNI MRI scans reoriented along the anterior commissure (AC) -- posterior commissure (PC) line using a six degrees of freedom linear transformation. We used the "preliminary release" version of the labels.

### 2.2.4. Training dataset (ADNI + AIBL) {#s0040}

The standardized ADNI dataset and the AIBL imaging arm were joined into one single training set for training of our method. This was possible because AIBL adopted the MRI protocol of ADNI, and because the neuropsychological tests in AIBL were designed to permit comparison and pooling with ADNI ([@bb0090]). We denote the combined dataset ADNI + AIBL.

### 2.2.5. CADDementia validation and test set {#s0045}

The challenge used 3 T T1-weighted scans collected from the following three sites; Erasmus MC, Rotterdam, The Netherlands (174 scans); VU Medical Center, Amsterdam, The Netherlands (180 scans); and University of Porto/Hospital de São João, Porto, Portugal (30 scans). Two versions of the MRI data were available; raw data, and a bias field corrected and skull stripped version of the data. We used the raw data and applied the same bias field correction method to all MRI scans from ADNI, AIBL and CADDementia.

2.3. Algorithm {#s0050}
--------------

The algorithm was based on a number of individual MRI imaging biomarkers ([Table 2](#t0010){ref-type="table"}); FreeSurfer cortical thickness measurements, FreeSurfer volumetric measurements, and hippocampal volume, shape and texture computed using special purpose methods. These biomarkers were z-score transformed within each group dependent on age, and entered as features to an LDA classifier as illustrated in [Fig. 1](#f0005){ref-type="fig"}.

Part of the FreeSurfer pipeline conforms the MRI scans to 1 × 1 × 1 mm^3^ resolution and corrects for bias field using the non-parametric non-uniform intensity normalization (N3) algorithm ([@bb0260]). The hippocampal shape and hippocampal texture methods used this representation of the MRI data as well. The special purpose hippocampal volume method utilized the additional anonical atlas-based intensity normalization step in FreeSurfer. Hippocampal shape and texture were computed based on the FreeSurfer segmentation of the hippocampus because this is an established method.

Throughout the presentation, we represent the *N*~class~ = 3 diagnostic groups as *ω*~1~ = NC, *ω*~2~ = MCI, and *ω*~3~ = AD.

### 2.3.1. FreeSurfer volumetry {#s0055}

Sub-cortical, whole brain, and ventricular volumetric measurements were computed using cross-sectional FreeSurfer ([@bb0110]). We used version 5.1.0 of FreeSurfer with default parameters. Bilateral ROIs were joined. All 7 volumetric measurements were normalized for head size by dividing by the intra-cranial volume (ICV) also computed during the cross-sectional FreeSurfer pipeline. The resulting feature vector looked as follows: $$\mathbf{x_{\text{volumetry}}} = \begin{bmatrix}
{(|\text{left\ amygdala}| + |\text{right\ amygdala}|)/\text{ICV}} \\
{(|\text{left\ caudate\ nucleus}| + |\text{right\ caudate\ nucleus}|)/\text{ICV}} \\
{(|\text{left\ hippocampus}| + |\text{right\ hippocampus}|)/\text{ICV}} \\
{(|\text{left\ pallidum}| + |\text{right\ pallidum}|)/\text{ICV}} \\
{(|\text{left\ putamen}| + |\text{right\ putamen}|)/\text{ICV}} \\
{(|\text{ventricular}|)/\text{ICV}} \\
{(|\text{whole\ brain}|)/\text{ICV}} \\
\end{bmatrix},$$where \|⋅\| denotes volume of an ROI. Note that \|⋅\| is computed by FreeSurfer and that partial volume effects are accounted for in this computation.

### 2.3.2. FreeSurfer cortical thickness {#s0060}

Cortical thickness measurements were computed using cross-sectional FreeSurfer (version 5.1.0, default parameters) ([@bb0105]). We used the Desikan-Killiany atlas that parcelates the entire cortex into 68 regions for each hemisphere. In order to keep the dimensionality of the feature vector low, the regions were joined into the four lobes and the cingulate cortex according to the specifications on the FreeSurfer website.[2](#fn0010){ref-type="fn"} Left and right hemispheres were further joined, resulting in a total of 5 cortical thickness measurements. We did not normalize cortical thickness measurements for head size (i.e., ICV) ([@bb0310]). The cortical thickness feature vector looked as follows: $$\mathbf{x_{\text{cortical\ thickness}}} = \begin{bmatrix}
{d(\text{left\ frontal\ lobe}) + d(\text{right\ frontal\ lobe})} \\
{d(\text{left\ occipital\ lobe}) + d(\text{right\ occipital\ lobe})} \\
{d(\text{left\ parietal\ lobe}) + d(\text{right\ parietal\ lobe})} \\
{d(\text{left\ temporal\ lobe}) + d(\text{right\ temporal\ lobe})} \\
{d(\text{left\ cingulate\ cortex}) + d(\text{right\ cingulate\ cortex})} \\
\end{bmatrix},$$where *d*(⋅) computes the average distance between the gray/white matter boundary and the pial surface of an ROI. Note that *d* is computed by FreeSurfer.

### 2.3.3. Multi-atlas, patch-based hippocampal volume {#s0065}

In addition to the FreeSurfer estimate of the hippocampal volume, we also computed the hippocampal volume using a special purpose algorithm. This was motivated by the fact that hippocampal volume is the most widely used MRI biomarker of AD ([@bb0155]), and since FreeSurfer segments many ROIs simultaneously in one objective function, it is not specific to a certain ROI. The left and right hippocampus were segmented separately using our own in-house implementation of the multi-atlas, non-local patch-based segmentation with expert priors technique ([@bb0070]). Manual delineations from HHP ([@bb0035]), representing state-of-the-art in manual hippocampus segmentation, were used as expert priors ([@bb0015], [@bb0020]). The method has previously demonstrated a better atrophy-based AD diagnostic performance than static FreeSurfer ([@bb0020]), and have in recent comparison studies performed by other research groups demonstrated better correspondence with manual segmentations than FreeSurfer ([@bb0200], [@bb0210]).

The atlas comprised the 40 segmentations in the HHP subset and their corresponding MRI scans, both transformed to a common atlas space using affine registration. When segmenting a new test MRI scan, the *N*~atlas~ closest atlases were selected from the candidate set of 40 HHP segmentations by registering each HHP MRI scan in the atlas set to the test MRI using an affine registration and computing the sum of squared differences between intensities inside the FreeSurfer skull-stripped area. The *N*~atlas~ corresponding manual hippocampus delineations were used in the subsequent computations.

Following [@bb0070], the left and right hippocampus were segmented separately using the following steps. In order to avoid unnecessary computations, only voxels inside a coarse mask obtained by the union of the manual delineations in the atlas were segmented in the test MRI scan. The segmented label $ŷ_{i}$ of a voxel **x**~*i*~ in the test MRI scan was obtained by thresholding a weighted label fusion of all labeled samples within the search volume from the *N*~atlas~ selected subjects $$ŷ_{i} = \left\{ \begin{matrix}
1 & {\text{if}\quad\frac{\sum\limits_{s = 1}^{N_{\text{atlas}\quad}}\sum\limits_{j \in V}w(\mathbf{x}_{i},\mathbf{x}_{s,j})y_{s,j}}{\sum\limits_{s = 1}^{N_{\text{atlas}\quad}}\sum\limits_{j \in V}w(\mathbf{x}_{i},\mathbf{x}_{s,j})} \geq 0.5} \\
0 & \text{otherwise} \\
\end{matrix} \right),$$where **x**~*s*,*j*~ is the voxel at position *j* in atlas *s* with corresponding HHP segmentation label *y*~*s*,*j*~ ∈{0,1} encoded according to whether voxel **x**~*s*,*j*~ is background or hippocampus, *V* is the search volume, and the label weights according to the similarity of the intensities in the two patches being compared is $$\begin{matrix}
{w(\mathbf{x},\mathbf{x}_{j,s}) = \left\{ \begin{matrix}
{\exp\left( \frac{- ||p(\mathbf{x}),p(\mathbf{x}_{s,j})||_{2}^{2}}{n^{3}h(\mathbf{x})} \right)} & {\text{if}\quad\tau(\mathbf{x},\mathbf{x}_{j,s}) > 0.95} \\
0 & \text{otherwise} \\
\end{matrix} \right),} \\
{\tau(\mathbf{x},\mathbf{x}_{j,s}) = \frac{2\mu_{p(\mathbf{x})}\mu_{p(\mathbf{x}_{s,j})}}{\mu_{p(\mathbf{x})}^{2} + \mu_{p(\mathbf{x}_{s,j})}^{2}} \times \frac{2\sigma_{p(\mathbf{x})}\sigma_{p(\mathbf{x}_{s,j})}}{\sigma_{p(\mathbf{x})}^{2} + \sigma_{p(\mathbf{x}_{s,j})}^{2}}.} \\
\end{matrix}$$Here *p*(**x**) extracts the *n*^3^-dimensional vector of concatenated intensities in the *n* × *n* × *n* patch centered on **x**, *h* is a smoothing parameter that locally adapts the similarity measure according to the distance of the closest atlas patch, and *μ*~*f*(**x**)~ and *σ*~*f*(**x**)~ are the mean and standard deviation of the intensities in patch *f*(**x**), respectively. In Eqs. ([3](#fo0015){ref-type="disp-formula"}) and ([4](#fo0020){ref-type="disp-formula"}), the thresholds were selected according to [@bb0070]. The threshold on *τ* serves as pre-selection of patches to reduce computational time. That is, dissimilar atlas patches are disregarded in the label fusion where similarity, *τ*, is computed as the product of simple measures of luminance and contrast difference. As proposed by [@bb0065], *h* was estimated according to $$h(\mathbf{x}) = 0.25\min\limits_{\mathbf{x}_{s,j}}||p(\mathbf{x}) - p(\mathbf{x}_{s,j})||_{2} + \epsilon,$$where *ϵ* is a small constant to avoid division by zero when the test patch is contained in the atlas.

The following parameter values were determined as the ones maximizing the leave-one-out estimation of Dice\'s coefficient on a subset of 15 HHP segmentations: •The number of atlases considered in initial atlas selection (*N*~atlas~) was set to 9.•A patch size (*n*) of 5 mm was used.•A search volume (*V*) size of 9 × 9 × 9 mm was used.

The final non-local patch (NL patch) feature was $$\mathbf{x}_{\text{NL\ patch}} = \frac{|\text{left\ hippocampus}| + |\text{right\ hippocampus}|}{\text{ICV}\quad},$$where ICV was estimated from the same MRI scan using FreeSurfer.

### 2.3.4. Hippocampal shape {#s0070}

Two hippocampal shape scores, one for the left and one for the right hippocampus, were computed as well. Each hippocampus was represented by a shape descriptor that was subsequently classified using a naïve Bayes classifier trained explicitly for left or right hipppocampus.

In a spirit similar to [@bb0005], the left and right hippocampus shape descriptors were computed using the following four steps:

1.A random subject was selected from the ADNI dataset as template and represented by 30 landmarks uniformly distributed across the surface of its FreeSurfer hippocampus segmentation.2.Each hippocampus was aligned to the template hippocampus using iterative closest point between the two respective FreeSurfer segmentations treated as point clouds. Subsequently, the pre-defined template surface landmarks were mapped to the aligned hippocampus by selecting its FreeSurfer segmentation surface points closest to the template surface points. As a result, each hippocampus was now represented by 30 surface landmarks, $\mathbf{x} = {\lbrack x_{1},y_{1},z_{1},\ldots,x_{30},y_{30},z_{30}\rbrack}^{T}$.3.The set of hippocampi represented as surface landmarks, {**x**}, were all aligned using generalized Procrustes alignment ([@bb0120]), producing a set of aligned shapes $\{\hat{\mathbf{x}}\}$.4.Finally, principal component analysis (PCA) was applied to the set of aligned hippocampus landmarks $\{\hat{\mathbf{x}}\}$, and the *N*~component~ components explaining 90% of the variance were retained, resulting in the final per-hippocampus shape descriptor $\widetilde{\mathbf{x}} = {\lbrack{\widetilde{x}}_{1},{\widetilde{x}}_{2},\ldots,{\widetilde{x}}_{N_{\text{component}}}\rbrack}^{T}$.

This representation was used as features in a 2-class Gaussian naïve Bayes classifier computing the posterior probability of AD $$f_{\text{naive\ Bayes}}(\text{AD}|\widetilde{\mathbf{x}}) = \frac{\exp g_{3}(\widetilde{\mathbf{x}}))}{\exp(g_{1}(\widetilde{\mathbf{x}})) + \exp(g_{3}(\widetilde{\mathbf{x}}))},$$where $g_{1}(\widetilde{\mathbf{x}})$ and $g_{3}(\widetilde{\mathbf{x}})$ are defined as $$g_{i}(\widetilde{\mathbf{x}}) = \sum\limits_{j = 1}^{N_{\text{component}}}\quad\left( {- \log\left( {\sqrt{2\pi}\sigma_{\omega_{i},j}} \right) - \frac{{({\widetilde{x}}_{j} - \mu_{\omega_{i},j})}^{2}}{2\sigma_{\omega_{i},j}^{2}}} \right) + \log P(\omega_{i})$$for *i* ∈{1,3}, where $\mu_{\omega_{i},j}$ and $\sigma_{\omega_{i},j}$ are the class-conditional mean and standard deviation for the *j*th component, and *P*(*ω*~*i*~) is the class prior.

The feature extraction was performed on all data simultaneously, i.e., on the combination of the training set and the test set. Subsequently, only NC and AD observations from the training set were used for training of the naïve Bayes classifier. The trained classifier was finally applied to score the test data. From a machine learning perspective, that means we make use of transductive inference ([@bb0290], chap. 8). The class priors in ([6](#fo0035){ref-type="disp-formula"}) were set to the class frequencies in the training set. The whole procedure was computed for the left and the right hippocampus separately, resulting in two shape scores. The FreeSurfer hippocampus segmentation was used to defined the left and right hippocampus ROI in each MRI scan. The shape feature vector looked as follows: $$\mathbf{x}_{\text{shape}} = \begin{bmatrix}
{f_{\text{naiveBayes}}(\mathbf{x}_{\text{leftShapeDescriptor}})} \\
{f_{\text{naiveBayes}}(\mathbf{x}_{\text{rightShapeDescriptor}})} \\
\end{bmatrix},$$where $\widetilde{\mathbf{x}}$ was computed for the left and right hippocampus separately to produce **x**~leftShapeDescriptor~ and **x**~rightShapeDescriptor~.

### 2.3.5. Hippocampal texture {#s0075}

A hippocampal texture score was computed using a texture descriptor that has previously been successfully applied for quantification of chronic obstructive pulmonary disease in computed tomography ([@bb0270]) in combination with a support vector machine (SVM) ([@bb0060]) with a radial Gaussian kernel. This specific MRI biomarker has previously shown good AD diagnostic results, captures independent information from volume, and has demonstrated capabilities of earlier AD detection than volume ([@bb0265]). Texture therefore complements volume well.

The texture descriptor comprised marginal filter response histograms of a 3-dimensional, rotation-invariant, multi-scale, Gaussian derivative-based filter bank ([@bb0195]). The histograms were computed using filter responses from both hippocampi collectively. These histograms could capture different micro-structural properties within the hippocampal tissue, such as the amount of steep intensity transitions and "blob"-like structures. The descriptor was adapted to our problem and therefore deviated from [@bb0270] in the following four ways:

1.The Gaussian filter was excluded in order to be invariant to the lack of a standard image intensity scale in MRI ([@bb0215]). This exclusion left the following seven base filters measuring different aspects of the local image structure: the three eigenvalues of the Hessian matrix, gradient magnitude, the Laplacian of the Gaussian, Gaussian curvature, and the Frobenius norm of the Hessian matrix. All these filters are based on intensity derivatives, and the method is therefore invariant to locally constant intensity offsets (e.g., caused by imperfections in the N3 bias field correction).2.The following scales were used: 0.6, 0.85, 1.2, and 1.7 mm. The upper end of the scale range was determined by visual inspection of Gaussian smoothed images. The structures in the hippocampus visually vanished at scales exceeding 1.7 mm.3.Derivatives at the different scales were computed by convolution with the corresponding derivative filter instead of convolution with a Gaussian followed by finite differencing for improved numerical accuracy.4.Based on the size of the smallest morphologically cleaned bilateral hippocampal segmentation in the ADNI dataset, we quantized the filter responses into nine histogram bins. The descriptor was applied to the conformed MRI scans, and since the FreeSurfer conformation and the filtering are both linear processes, their combination is mathematically equivalent to one linear process.

In the following, *I*~*x*,*σ*~ and *I*~*xx*,*σ*~ denote the partial first order and second order derivative, respectively, of MRI image *I* w.r.t. *x* at scale *σ*, and **x** = \[*x*,*y*,*z*\]^*T*^ is a voxel. Partial derivatives of the image at the different scales in the multi-scale representation of the image were in all cases obtained using Gaussian derivatives ([@bb0195]). For example, *I*~*x*,*σ*~ = *I* ∗ *G*~*x*,*σ*~ where ∗ denotes convolution and *G*~*x*,*σ*~ is the partial first-order derivative of the Gaussian function, $$G(\mathbf{x};\sigma) = \frac{1}{{({(2\pi)}^{(1/2)}\sigma)}^{3}}\exp\left( {- \frac{||\mathbf{x}||_{2}^{2}}{2\sigma^{2}}} \right),$$w.r.t. *x* at scale *σ*. This way of defining derivatives in scale-space makes the computation of image derivatives well-posed ([@bb0195]). The seven base filters in the filter bank of the texture descriptor were the following: the three eigenvalues of the Hessian matrix $$\lambda_{i}(\mathbf{x};\sigma),\quad i \in \{ 1,2,3\},\quad|\lambda_{1}(\mathbf{x};\sigma)| \geq |\lambda_{2}(\mathbf{x};\sigma)| \geq |\lambda_{3}(\mathbf{x};\sigma)|,$$where $$H(\mathbf{x};\sigma) = \begin{bmatrix}
I_{xx,\sigma} & I_{xy,\sigma} & I_{xz,\sigma} \\
I_{xy,\sigma} & I_{yy,\sigma} & I_{yz,\sigma} \\
I_{xz,\sigma} & I_{yz,\sigma} & I_{zz,\sigma} \\
\end{bmatrix};$$gradient magnitude $$||\nabla G(\mathbf{x};\sigma)||_{2} = \sqrt{I_{x,\sigma}^{2} + I_{y,\sigma}^{2} + I_{z,\sigma}^{2}};$$Laplacian of the Gaussian $$\nabla^{2}G(\mathbf{x};\sigma) = \lambda_{1}(\mathbf{x};\sigma) + \lambda_{2}(\mathbf{x};\sigma) + \lambda_{3}(\mathbf{x};\sigma);$$Gaussian curvature $$K(\mathbf{x};\sigma) = \lambda_{1}(\mathbf{x};\sigma)\lambda_{2}(\mathbf{x};\sigma)\lambda_{3}(\mathbf{x};\sigma);$$and the Frobenius norm of the Hessian $$||H(\mathbf{x};\sigma)||_{F} = \sqrt{\lambda_{1}{(\mathbf{x};\sigma)}^{2} + \lambda_{2}{(\mathbf{x};\sigma)}^{2} + \lambda_{3}{(\mathbf{x};\sigma)}^{2}}.$$

The histogram of filter responses inside the hippocampus in a filtered MRI image was estimated as $$h_{f}(i,I) = \frac{\sum\limits_{\mathbf{x} \in S}\delta_{i}(I_{f}(\mathbf{x}))}{|S|},\quad i = 1\ldots 9,$$where *S* is the joined left and right hippocampus segmentation computed from *I* using the static FreeSurfer pipeline, *I*~*f*~ is *I* filtered using filter *f*, and *δ*~*i*~(⋅) is an indicator function defined as $$\delta_{i}(I_{f}(\mathbf{x})) = \left\{ \begin{matrix}
1 & {{if}\Delta_{i} < I_{f}(\mathbf{x}) < \Delta_{i + 1}} \\
0 & \text{otherwise} \\
\end{matrix} \right),$$where *Δ*~*i*~ is a histogram bin edge. The edges were determined using adaptive binning ([@bb0220]); *Δ*~*i*~ is the (*i* − 1)/*N*~bin~ × 100th percentile filter response in the training set where *N*~bin~ is the number of histogram bins. In this work, morphologically post-processed bilateral FreeSurfer hippocampus segmentations were used to define the ROI, and the number of histogram bins was determined as $N_{\text{bin}\quad} = \left\lfloor \sqrt[3]{731} \right\rfloor = 9$ in the experiments. The smallest morphologically cleaned bilateral FreeSurfer hippocampal segmentation in the ADNI dataset, which contained 731 voxels, determined this number.

The final hippocampal texture descriptor was obtained by concatenating the filter response histograms; $$\mathbf{x}_{\text{textureDescriptor}} = {\lbrack h_{\lambda_{1}(x;0.6)},\ldots,h_{||H(x;0.6)||_{F}},\ldots,h_{||H(x;1.7)||_{F}}\rbrack}^{T}.$$

The concatenated histograms were used as input features *x* to a support vector machine (SVM) ([@bb0060]) trained using the NC and AD observations from the training set. The SVM discriminant function $$f_{\text{SVM}}(x) = \sum\limits_{i = 1}^{N_{\text{train}}}a_{i}k(x_{i},x) + b$$was used for texture scoring. It is determined by solving $$\underset{a \in {\mathbb{R}}^{N_{\text{train}}},b \in {\mathbb{R}}}{\text{minimize}}\sum\limits_{i = 1}^{N_{\text{train}}}L_{\text{hinge}}(y_{i},f_{\text{SVM}}(x_{i})) + \frac{1}{2C}\sum\limits_{i = 1,j = 1}^{N_{\text{train}\quad}}a_{i}a_{j}k(x_{i},x_{j})$$where $x_{i} \in \mathcal{X}$ ($i = 1,\ldots,N_{\text{train}}$) is a training pattern and *y*~*i*~ ∈{ −1,1} encodes the class label according to whether pattern *i* is labeled NC or AD, the loss function is defined as $L_{\text{hinge}}(y,ŷ) = \max(0,1 - yŷ)$, and *k*(⋅,⋅) is the radial Gaussian kernel, $$k(x_{i},x) = \exp( - \gamma||x_{i} - x||_{2}^{2}).$$The regularization parameter *C* \> 0 and the kernel parameter *γ* \> 0 were selected using grid search. We considered the following hyperparameter values in the grid: $\log(C) \in \{ 0,1,\ldots,10\}$ and $\log(\gamma) \in {\{\log(\gamma_{\text{Jaakkola}}) - 4 + 1/3i\}}_{i = 0,1,\ldots,24}$, where $$\begin{aligned}
{\gamma_{\text{Jaakkola}} = \text{median}\{\min\{||x_{i} -} & {x_{j}||_{2}|(x_{j},y_{j})} \\
\quad & {\in S \land y_{i} \neq y_{j}\}|(x_{i},y_{i}) \in S\}} \\
\end{aligned}$$provided an initial guess for *γ* around which the grid search was centered ([@bb0145]). The performance of each parameter combination (*C*,*γ*) was estimated using 20-fold cross-validation splitting the available training data stratified by class label. The parameter combination that resulted in the lowest cross-validation AUC was selected, and the SVM was finally trained on the complete training set using these parameters.

The final hippocampal texture score was obtained by applying the trained SVM to the textural description of an observation $$\mathbf{x}_{\text{texture}} = f_{\text{SVM}}(\mathbf{x}_{\text{textureDescriptor}}).$$

### 2.3.6. Age-dependent z-score transformation and classification {#s0080}

The individual MRI biomarker feature vectors, Eqs. ([1](#fo0005){ref-type="disp-formula"}), ([2](#fo0010){ref-type="disp-formula"}), ([5](#fo0030){ref-type="disp-formula"}), ([6](#fo0045){ref-type="disp-formula"}) and ([7](#fo0120){ref-type="disp-formula"}), were concatenated into one 16-dimensional combined feature vector $$\mathbf{x}_{\text{combination}} = {\lbrack\mathbf{x}_{\text{volumetric}},\mathbf{x}_{\text{cortical\ thickness}},\mathbf{x}_{\text{NL\ patch}},\mathbf{x}_{\text{shape}},\mathbf{x}_{\text{texture}}\rbrack}^{T}.$$

Each entry *x* in **x**~combination~ was normalized for age using a z-score transformed dependent on the age of the subject according to *z* = (*x* − *μ*~age~)/*σ*~age~. The age-dependent weighted mean, *μ*~age~, and the age-dependent weighted standard deviation, *σ*~age~, of the biomarker used in the transformation were estimated from the training set using an adaptive width Gaussian interpolation kernel centered on the respective age. The age-dependent z-score transformation was applied for each diagnostic group, resulting in a 48-dimensional feature vector **z**~combination~ that was used as the final representation in the algorithm.

The combined and z-score transformed MRI biomarkers were classified using a 3-class LDA classifier. Either as a hard classification $$f_{\text{hardLDA}}(\mathbf{z}_{\text{combination}}) = \underset{i = 1,\ldots,N_{\text{class}}\quad}{\text{argmax}}g_{i}(\mathbf{z}_{\text{combination}})$$or as a posterior probability computed using the softmax function $$f_{\text{softLDA}}(\omega_{i}|\mathbf{z}_{\text{combination}}) = \frac{\exp(g_{i}(\mathbf{z}_{\text{combination}}))}{\sum\limits_{j = 1}^{N_{\text{class}}}\exp(g_{j}(\mathbf{z}_{\text{combination}}))}.$$In both cases, *g*~*i*~(⋅) is the LDA discriminant function $$g_{i}\left( \mathbf{z}_{\text{combination}} \right) = \mathbf{z}_{\text{combination}}^{T}\mathbf{\Sigma}^{- 1}\mathbf{\mu}_{\omega_{i}} - \frac{1}{2}\mathbf{\mu}_{\omega_{i}}^{T}\mathbf{\Sigma}^{- 1}\mathbf{\mu}_{\omega_{i}} + \log P\left( \omega_{i} \right)$$where $\mathbf{\mu}_{\omega_{i}}$ is the class-conditional mean and ***Σ*** is the pooled covariance matrix. LDA training and classification was performed using the open source C++ machine learning library Shark ([@bb0140]). The class priors in were set to the class frequencies in the training set.

3. Results and discussion {#s0085}
=========================

The CADDementia data was scored using the LDA classifier trained on all ADNI + AIBL data. The ADNI + AIBL dataset was scored using 10-fold cross-validation stratified by cohort (ADNI, AIBL) and diagnostic group (NC, MCI, AD). The same folds were used to obtain individual hippocampal shape and hippocampal texture scores, and to obtain scores from the combination LDA. When scoring CADDementia data, hippocampal shape features were extracted from the combination of ADNI + AIBL and either the CADDementia validation set (the number of components, *N*~component~, retained in the PCA were 50 for the left hippocampus and 48 for the right hippocampus) or the CADDementia test set (51 PCA components for the left hippocampus and 49 for the right hippocampus), dependent on which dataset was to be scored, and in the 10-fold cross-validation procedure used to score the ADNI + AIBL dataset, hippocampal shape features were extracted using the entire ADNI + AIBL dataset (50 PCA components for the left hippocampus and 48 for the right hippocampus). Because the shape features were extracted in this way, we perform transductive inference.

FreeSurfer failed to process three scans in the CADDementia test set. This was handled by imputing features. For two cases, the FreeSurfer pipeline had reached past the sub-cortical segmentation step, but not far enough to produce stats-files with partial volume corrected volume estimates, nor cortical thickness measurements. For these cases, we assigned the mean of the class with the most similar texture score because we could still compute this. The last cased failed before sub-cortical segmentation. Here we performed a visual inspection and assigned the mean of the NC class.[3](#fn0015){ref-type="fn"}

3.1. Diagnostic results {#s0090}
-----------------------

Diagnostic measures for the CADDementia validation set and ADNI + AIBL were obtained using the Python scripts supplied by the CADDementia team on our scores, and the CADDementia test set performance was obtained from the challenge itself.

The combination biomarker achieved a CA of 63.0*%* and a total AUC of 78.5 on the CADDementia challenge test set ([Table 3](#t0015){ref-type="table"}). This was comparable to the CA and total AUC estimated using 10-fold cross-validation on ADNI + AIBL. The performance on the CADDementia validation set was substantially better with a CA of 73.3*%* and a total AUC of 83.2. We attribute this discrepancy to the rather small size of the CADDementia validation set (30 observations). Better performance on the CADDementia validation set was observed across all participating teams ([@bb0045]). The TFPs and the confusion matrices in [Table 4](#t0020){ref-type="table"} reveals that on a diagnostic group level, the results between the CADDementia test set and ADNI+AIBL were less comparable with absolute true positive fraction differences in the range 17.9*%* to 29.1*%*. The discrepancy could be explained by cohort differences. For example, the CADDementia subjects are on average 10 years younger than ADNI and AIBL subjects ([Table 1](#t0005){ref-type="table"}). However, we would not expect age to be the primary cause because of the age-dependent z-score transformation of the individual MRI biomarkers prior to entering the LDA. Another possible cause is difference in MRI field strength, the CADDementia data is 3 T whereas ADNI is 1.5 T. However, the addition of the 144 3 T AIBL scans to the training set should to some degree account for this. Moreover, we would expect field strength to play a smaller role because this would imply a shift in features across the entire dataset, not within specific diagnostic groups. Another potential cause is differences in the criteria for the diagnostic groups, i.e., how the labels are defined. Approximately half the CADDementia NC group are controls with subjective complaints ([@bb0045]) as opposed to only 20*%* in ADNI + AIBL. ADNI explicitly defines NC to be controls with no memory complaints ([@bb0235]), and by design, approximately 50*%* of controls in AIBL had subjective memory complaints ([@bb0090]). ADNI and AIBL include only mild AD patients at baseline ([@bb0235], [@bb0090]) as opposed to CADDementia that does not restrict the severity ([@bb0045]). The AD patients in the training dataset had mean mini-mental state examination (MMSE) scores of 23.2 ± 1.9 and 21.2 ± 5.6, for the ADNI and AIBL parts, respectively. In comparison, the AD patients from the VU Medical Center, which amounts to approximately half of the AD patients in the CADDementia dataset, had a mean MMSE score of 20 ± 4.6 ([@bb0030]).

In comparison to the results of the other participating teams in the CADDementia challenge, the 63.0*%* CA was significantly better than the methods not in top-six according to a McNemar\'s test on the hard classification output ([@bb0045]). The total AUC of 78.5 was also the highest among all entries and only the top-five methods had AUCs within the lower AUC confidence interval of our method ([@bb0045]).

3.2. Feature contribution {#s0095}
-------------------------

In order to inspect the contribution of each feature in classification, we performed a feature selection experiment using sequential forward feature selection (SFS) ([@bb0165]). The objective function in the SFS procedure was the 20-fold cross-validation CA of an LDA classifier applied to the training set. We used the training set folds from the ADNI + AIBL 10FCV dataset and computed the average CA curve as a function of the number of selected features across the 10 folds ([Fig. 2](#f0010){ref-type="fig"}A). The curve converged at 10 features, and this was the number of features retained in the subsequent analysis. The frequency of selection when keeping the first 10 features in each of the 10 folds was computed ([Fig. 2](#f0010){ref-type="fig"}B). In this analysis, a feature could be selected a maximum of 30 times (3 different z-score representations across 10 folds). The most frequently selected features were as follows (reported as % of possible): FreeSurfer hippocampal volume (66.7%), FreeSurfer ventricular volume (53.3%), hippocampal texture (50.0%), FreeSurfer parietal lobe thickness (46.7%), right hippocampal shape (23.3%), FreeSurfer occipital lobe thickness (20.0%), and FreeSurfer cingulate cortex thickness (20.0%). In addition, we analyzed how early a feature was selected (indicated by color-coding in [Fig. 2](#f0010){ref-type="fig"}B). Hippocampal texture was consistently selected in the first iteration of the SFS procedure in all 10 folds, FreeSurfer hippocampal volume was selected in the second iteration in 9 folds and in the third iteration in 1 fold, and FreeSurfer ventricular volume was selected in 1 fold in the second iteration and in 6 folds in the third iteration. The following feature subsets occurred most frequently in the 10 folds: {hippocampal texture, FreeSurfer hippocampal volume, FreeSurfer ventricular volume} (10 folds), {hippocampal texture, FreeSurfer hippocampal volume, FreeSurfer ventricular volume, FreeSurfer parietal lobe thickness} (9 folds), {hippocampal texture, FreeSurfer hippocampal volume, FreeSurfer ventricular volume, FreeSurfer occipital lobe thickness} (6 folds), and {hippocampal texture, right hippocampus shape, FreeSurfer hippocampal volume, FreeSurfer ventricular volume} (5 folds). The reduced feature representation (i.e., using the first 10 features as selected by SFS on the training set in each fold of the 10-fold cross-validation procedure) resulted in a 62.6% CA on the ADNI + AIBL dataset. This was similar to the 62.7% CA obtained when using the full feature representation.

To gain insight into which features contribute to discrimination between two specific diagnostic groups, we repeated the SFS for each pairwise scenario (NC vs.MCI, NC vs.AD, MCI vs.AD) using a 2-class LDA as objective function. When considering NC vs.MCI, the picture was similar to the 3-class scenario; hippocampal texture was consistently selected as the first feature in all 10 folds, and FreeSurfer hippocampal volume (50.0%) and ventricular volume (50.0%) were alongside hippocampal texture (56.7%) the most frequently selected features. However, the selection frequency for FreeSurfer parietal lobe thickness dropped to 30.0%, whereas FreeSurfer occipital lobe thickness increased its frequency to 33.3%. The picture changed completely when considering MCI vs.AD. In this case, the FreeSurfer temporal lobe thickness was selected as the first feature in 8 out of 10 folds and FreeSurfer parietal lobe thickness was selected first in the 2 remaining folds, and the distribution of selection was more uniform with FreeSurfer amygdala volume (40.0%), FreeSurfer temporal lobe thickness (40.0%), NL patch (36.7%), and FreeSurfer occipital lobe thickness (33.3%) as the most frequently selected features. For NC vs.AD, the frequency of selection was the most peaked and a mix of previous tendencies was observed. Hippocampal texture was selected first in 9 out of 10 folds whereas FreeSurfer temporal lobe thickness was selected in the remaining fold. The most frequent features were as follows: FreeSurfer temporal lobe thickness (63.3%), FreeSurfer hippocampus volume (50.0%), and hippocampal texture (36.7%).

3.3. Feature relations {#s0100}
----------------------

We inspected the relationship between the features entered to the LDA by computing their pair-wise Pearson correlation ([Table 5](#t0025){ref-type="table"}). Prior to computing correlation, each feature was aggregated across the 3 per-group z-scores by computing the mean feature value. As expected, the most correlated features were the two hippocampal volume estimates from FreeSurfer and NL patch that had a correlation of *ρ* = 0.9. Other expected high correlations included the volume of the hippocampus and of the amygdala ([@bb0240]) (*ρ* = 0.8 and *ρ* = 0.7, depending on hippocampal volume estimation method), and hippocampal volume vs.hippocampal texture (*ρ* = −0.7 and *ρ* = −0.6). The cortical thickness features were generally highly correlated, with one insignicifant correlation and 9 significant correlations ranging from *ρ* = 0.5 to *ρ* = 0.8 among the 10 pair-wise combinations. Finally, we note that the temporal lobe was the only cortical thickness feature that correlated with volumetric and special purpose hippocampus features, and that the highest correlation was with hippocampal texture (*ρ* = −0.7).

3.4. Sufficient training data? {#s0105}
------------------------------

The learning curves of the combination biomarker were plotted in order to determine whether the method would have benefited from more training data. In a spirit similar to [@bb0225], the curves were computed based on ADNI + AIBL as follows:

1.ADNI + AIBL is initially split randomly stratified by cohort and diagnostic group into a validation set *X*~validation~ of size 49 and the remaining 600 observations are kept as training data pool *X*~train-source~.2.Repeat for $N = 50,100,\ldots,600$.(a)A training set *X*~train~ of current size *N* is sampled without replacement from *X*~train-source~.(b)The combination LDA is trained on *X*~train~ and is subsequently applied to score both *X*~train~ and *X*~validation~. The resulting classification accuracies are recorded.

The above procedure is repeated 100 times, and the mean and standard deviation of the resulting training curves produce the final training learning curve. The final validation learning curve was obtained in a similar manner.

The curves are converging and approach each other ([Fig. 3](#f0015){ref-type="fig"}A), suggesting that further increasing the amount of training data would only have a small effect on the performance. The learning task appears to be a "high bias" problem. However, one should also bear in mind that the Bayes optimal error for this problem is not zero. First, there is noise in the labels because the diagnosis is clinical and a definite diagnosis would only be possible post-mortem. CADDementia uses the NINCDS/ADRDA criteria for probable AD ([@bb0205]) to define the AD group, and an average sensitivity of 81% across several studies at a specificity of 70% have been reported for these criteria when compared to neurological confirmation ([@bb0180]). The MCI group is also based on a clinical diagnosis ([@bb0230]), and MCI is in general a heterogeneous entity. Both properties may lead to label noise as well. Secondly, we expect there is a limit as to what structural MRI is capable of in isolation, especially when MCI is part of the problem. According to recent hypothetical models of AD biomarker dynamics, structural MRI is one of the biomarkers that are dynamic late during the disease process ([@bb0160]).

3.5. A more complex classifier? {#s0110}
-------------------------------

One way to approach a high bias problem is to use a more flexible classifier, possibly in combination with more training data. In order to test this, we repeated the learning curve experiment with the following three non-linear classifiers: •a radial Gaussian SVM. Regularization and kernel parameter were determined using grid search, and the performance of each parameter combination was estimated using 20-fold cross-validation on the training set in a particular fold;•a random forest classifier. The split in each node of a tree in the random forest classifier was done on $\left\lfloor \sqrt{48} \right\rfloor = 6$ features ([@bb0125]), and 500 trees were used in the ensemble;•a k nearest neighbor (kNN) classifier. Euclidean distance and k chosen according to the usual square root rule ([@bb0010]): $k = \left\lfloor \sqrt{N_{\text{train}\quad}} \right\rfloor$ where *N*~train~ is the number of training set observations in a particular fold.

It was observed that the curves of the non-linear classifiers converged to a performance similar to the LDA, and that the training and validation curves met each other ([Fig. 3](#f0015){ref-type="fig"}B--D). Therefore, we conjecture that for the given features, we are close to the Bayes optimal solution.

3.6. General discussion {#s0115}
-----------------------

Structural MRI is among the core biomarkers of AD ([@bb0160]). It is considered a surrogate marker of neurodegeneration and has generally been shown to be sensitive relatively late during the course of the disease. However, the placement of structural MRI in the hypothetical model of AD biomarker dynamics put forward by [@bb0160] is based on evidence from volumetric MRI studies. There are other MRI-based biomarkers that target subtler information, such as the hippocampal shape and hippocampal texture, both considered in this study. These MRI biomarkers have been shown to be predictive of dementia independent of volume ([@bb0005], [@bb0265]), and there is reason to believe that combining volume with these markers would increase the range over which structural MRI is sensitive to the course of AD.

Apart from our method, two other top-performing methods in the CADDementia challenge also used a combination of diverse MRI biomarkers ([@bb0045]), highlighting the benefit of combining different information. [@bb0295] used a combination of volume, cortical thickness, and shape of different brain ROIs, and [@bb0185] used a combination of volume and cortical features including thickness in specific ROIs and intensity and texture in data-driven areas of the brain. The benefit of combining diverse MRI biomarkers was further emphasized by the five methods proposed by [@bb0185]. Four submissions were based on the aforementioned four different types of features, and a fifth submission combined all four types of features. The combination of all four types of features proved to perform best, both in the challenge ([@bb0045]) and on ADNI data ([@bb0185]).

In order to improve the results obtained using our method, more features would be needed. This could potentially be extraction of more information from the MRI scan. For example, extending texture and shape computation to other regions of the brain than the hippocampus. Texture and shape of other regions have already been successfully applied in AD ([@bb0050], [@bb0285]), and in the CADDementia challenge, [@bb0295] achieved good performance using the shape of as many as 44 different ROIs and [@bb0185] extracted texture from the entire brain. However, it may also be the case that the performance achieved among the top performing methods in the CADDementia challenge are at the limit of what a single structural T1-weighted MRI scan is capable of for this type of problem. Another option would be to include imaging biomarkers based on other MRI modalities such as fluid-attenuated inversion recovery or gradient-echo sequences to quantify vascular lesions that may coexist alongside AD pathology ([@bb0320]).

Many methods in the CADDementia challenge, including our method, achieved a low true positive fraction for MCI ([@bb0045]). MCI is, in general, difficult to classify because it is a heterogeneous group in between NC and AD. The difference between true positive fractions for our method for the CADDementia test dataset (28.7%) compared with ADNI + AIBL (57.8%) further indicates that the MCI group in the challenge was particularly difficult to discriminate. Moreover, the combination of the low true positive fraction and the tendency for subjects with MCI to be misclassified as NC ([@bb0045]) indicate that CADDementia contained early MCIs, which potentially increased the difficulty of the classification problem because structural MRI is a late AD biomarker ([@bb0160]). Core biomarkers of AD that can detect the disease earlier than structural MRI directly measure abnormal protein build-up in cerebrospinal fluid (CSF) or use positron-emission tomography (PET) ([@bb0160]). There is, therefore, great potential in combining our MRI biomarker with these biomarkers for improved discrimination, especially of NC and MCI. Unfortunately, these biomarkers are more invasive, are not easily accessible, and are in some cases more costly, when compared with MRI, and blood-based biomarkers of protein build-up ([@bb0130]) may be a more viable candidate for combination with our MRI biomarker in the future.

The true positive fraction of MCI could be increased in our method by increasing the prior for MCI in the LDA. This would push the decision boundary between NC and MCI in the direction of NC with to effect of more correctly classified MCIs. This may, however, deteriorate the overall performance as exemplified by the second score we produced for the CADDementia challenge where the LDA priors were adapted to balance the confusion matrix in the CADDementia validation dataset ([@bb0275]).

Two versions of the hippocampal volume, FreeSurfer\'s estimate and NL patch, were included as features in the method for increased robustness for this central MRI imaging biomarker in AD. The hippocampus is affected early and severely in the AD pathological process ([@bb0040], [@bb0305]), and the volume of this brain structure is the most widely applied ([@bb0155]) and only qualified ([@bb0135]) MRI imaging biomarker in AD. It turned out that only one of the two hippocampal volume estimates contributed, and which contributed depended on the classification scenario. NL patch was selected when the two-class scenario MCI vs.AD was considered in the feature selection experiment while the FreeSurfer estimate was selected in the other scenarios. This should, however, be interpreted in conjunction with the other selected features, since restricting the algorithm to use only one of the hippocampal volume estimates as feature produced the following AUCs (reported as NC vs.MCI vs.AD/NC vs.MCI/NC vs.AD/MCI vs.AD): FreeSurfer 0.74/0.77/0.89/0.65 and NL patch 0.70/0.74/0.85/0.61.

4. Conclusions {#s0120}
==============

We propose the combination of volumetry, cortical thickness, hippocampal shape, and hippocampal texture for differential diagnosis of NC, MCI, and AD using a single T1-weighted structural MRI scan. The combination of such diverse MRI biomarkers resulted in a multi-class CA of 62.7% on publicly available reference datasets (ADNI and AIBL). A similar CA of 63.0% was achieved in the CADDementia challenge, which resulted in a first place in the competition. The forward feature selection experiments revealed that hippocampal texture was the most important feature in the algorithm followed by hippocampal volume, ventricular volume, and parietal lobe thickness. The learning curve results, along with the fact that other challenge participants using relatively similar features and training data did not surpass our performance, indicate that other types of information are needed in order to improve beyond the obtained performance for this type of problem, for example, other MRI modalities or non-MRI core biomarkers of AD.

In summary, this paper •describes and analyzes the winning algorithm in the CADDementia challenge;•shows the importance of hippocampal texture as a feature in the algorithm; and•conjectures that additional (possibly non-structural MRI) features are needed in order to significantly improve diagnostic performance.
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Another team participating in the CADDementia challenge also reported problems in FreeSurfer processing of 3 cases using FreeSurfer v5.1 ([@bb0295]).

![Sketch illustrating the algorithm. (A) A range of individual structural MRI biomarkers capturing different aspects of the scan are extracted. (B) The individual MRI biomarkers are z-score normalized dependent on the age of the subject with respect to each diagnostic group. (C) The z-score normalized MRI biomarkers are entered to a 3-class LDA classifier to produce the combination biomarker score. A hard classification was obtained using *f*~hardLDA~(**z**~combination~), and a soft classification was obtained using *f*~softLDA~(*ω*~*i*~\|**z**~combination~).](gr1){#f0005}

![Result of sequential forward feature selection (SFS). (A) Performance as a function of number of selected features. The thin gray lines correspond to each of the 10 training sets in the ADNI+AIBL 10FCV dataset, and the thick black line is the average performance across the 10 training folds. The average curve converges at 10 features indicated by the gray circle. This is the number of features that is used in the subsequent analysis. (B) Frequency of selection when the first 10 features are considered in the SFS. Each feature can be selected maximally 30 times (corresponding to the 3 different z-score versions across the 10 folds). The color-coding corresponds to how early in the SFS procedure a feature is selected, and it ranges from white (1. iteration) to black (10. and last iteration).](gr2){#f0010}

![Learning curves with MRI biomarkers as features. (A) LDA (the classifier used in the CADDementia challenge). (B) SVM with a radial Gaussian kernel. (C) Random forest classifier. Note that the training curve is not shown here because the training CA by design is ≈ 100*%*. (D) kNN classifier. Error bars mark ±standard deviation. The dashed black curve corresponds to the mean ADNI + AIBL validation accuracy of the LDA classifier, i.e., the green curve in (A).](gr3){#f0015}

###### 

Characteristics of the datasets.

                              n     Age, years   Male   MMSE[a](#tf0020){ref-type="table-fn"}   Field strength
  --------------------------- ----- ------------ ------ --------------------------------------- ----------------
  ADNI standardized dataset                                                                     
   All                        504   75.3 ± 6.5   58.1   27.0 ± 2.6                              504/0
   NC                         169   76.0 ± 5.1   50.9   29.2 ± 1.0                              169/0
   MCI                        234   74.9 ± 7.0   66.7   27.1 ± 1.7                              234/0
   AD                         101   75.3 ± 7.4   50.5   23.2 ± 1.9                              101/0
  ADNI HHP subset                                                                               
   All                        40    74.0 ± 7.6   47.5   26.3 ± 2.9                              40/0
   NC                         13    75.9 ± 6.8   46.2   28.8 ± 1.1                              13/0
   MCI                        11    70.4 ± 7.4   54.5   27.5 ± 1.2                              11/0
   AD                         16    74.9 ± 8.0   43.8   23.4 ± 2.0                              16/0
  AIBL imaging arm                                                                              
   All                        145   75.4 ± 7.4   46.2   27.1 ± 4.0                              1/144
   NC                         88    75.2 ± 7.2   47.7   28.9 ± 1.3                              1/87
   MCI                        29    77.5 ± 7.1   51.7   27.0 ± 2.0                              0/29
   AD                         28    73.6 ± 8.1   35.7   21.2 ± 5.6                              0/28
  CADDementia validation                                                                        
   All                        30    65.2 ± 7.0   43.3                                           0/30
   NC                         12    62.3 ± 6.3   25.0                                           0/12
   MCI                        9     68.0 ± 8.5   44.4                                           0/9
   AD                         9     66.1 ± 5.2   66.7                                           0/9
  CADDementia test                                                                              
   All                        354   65.1 ± 7.8   60.2                                           0/354

MMSE was not available for the CADDementia data.

###### 

Overview of individual MRI biomarkers.

  MRI biomarker                 ROI segmentation   Training dataset
  ----------------------------- ------------------ ------------------
  Cortical thickness                               
   Frontal lobe                 FreeSurfer         No training
   Occipital lobe               FreeSurfer         No training
   Parietal lobe                FreeSurfer         No training
   Temporal lobe                FreeSurfer         No training
   Cingulate cortex             FreeSurfer         No training
  Volumetry                                        
   Amygdala                     FreeSurfer         No training
   Caudate nucleus              FreeSurfer         No training
   Hippocampus                  FreeSurfer         No training
   Pallidum                     FreeSurfer         No training
   Putamen                      FreeSurfer         No training
   Ventricular                  FreeSurfer         No training
   Whole brain                  FreeSurfer         No training
  Special purpose hippocampus                      
   NL patch                     NL patch           HHP
   Left hipppocampus shape      FreeSurfer         ADNI + AIBL
   Right hipppocampus shape     FreeSurfer         ADNI + AIBL
   Hippocampal texture          FreeSurfer         ADNI + AIBL

###### 

Performance measures.

                                                      CA     True positive fraction   AUC                                
  --------------------------------------------------- ------ ------------------------ ------ ------ ------ ------ ------ ------
  ADNI + AIBL[a](#tf0025){ref-type="table-fn"}        62.7   79.0                     57.8   40.3   78.1   86.1   68.3   81.8
  CADDementia validation                              73.3   91.7                     44.4   77.8   83.2   86.6   68.3   95.8
  CADDementia test[b](#tf0030){ref-type="table-fn"}   63.0   96.9                     28.7   61.2   78.8   86.3   63.1   87.5

10-Fold cross-validation stratified by cohort and diagnostic group.

Results from [@bb0045].

###### 

Confusion matrices. Rows are predicted class and columns are true class.

  ADNI+AIBL[a](#tf9025){ref-type="table-fn"}   CADDementia validation   CADDementia test[b](#tf9030){ref-type="table-fn"}                                            
  -------------------------------------------- ------------------------ --------------------------------------------------- ---- ----- ---- --- --- ----- ----- ---- ----
  NC                                           203                      65                                                  9    NC    11   3   0   NC    125   64   15
  MCI                                          48                       152                                                 68   MCI   1    5   2   MCI   3     35   25
  AD                                           6                        46                                                  52   AD    0    1   7   AD    1     23   63

10-fold cross-validation stratified by cohort and diagnostic group.

results from [@bb0045].

###### 

Pair-wise Pearson correlation between features. Asterisk marks significance Bonferroni corrected across pair-wise comparisons (*p* \< 0.000008 = 0.001/((16^2^ − 16)/2)). Bold font marks significant correlations of at least 0.5.
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  CN          0.1                             0.2^\*^                0.2^\*^                       0.1            0.1        0.2^\*^                                                                                                                     
  HI          0.4^\*^                         0.3^\*^                0.4^\*^                       **0.**6^\*^    0.4^\*^    **0.**8^\*^    0.1                                                                                                          
  PA          0.2^\*^                         0.2^\*^                0.2^\*^                       0.2^\*^        0.1        0.3^\*^        0.3^\*^       0.4^\*^                                                                                        
  PU          0.3^\*^                         0.4^\*^                0.4^\*^                       0.4^\*^        0.3^\*^    **0.**5^\*^    **0.**6^\*^   **0.**5^\*^    **0.**5^\*^                                                                     
  VE          −0.3^\*^                        −0.2                   −0.2^\*^                      −0.4^\*^       −0.3^\*^   −0.3^\*^       0.1           **−0.**5^\*^   −0.4^\*^      −0.4^\*^                                                          
  WB          0.2^\*^                         0.2^\*^                0.2^\*^                       0.2^\*^        0.2^\*^    0.4^\*^        0.3^\*^       **0.5**^\*^    **0.5**^\*^   **0.5**^\*^   −0.3^\*^                                            
  NL patch    0.3^\*^                         0.2^\*^                0.2^\*^                       **0.5**^\*^    0.3^\*^    **0.7**^\*^    0.1           **0.9**^\*^    0.4^\*^       0.4^\*^       −0.4^\*^   0.4^\*^                                  
  Shape (l)   −0.2^\*^                        −0.2^\*^               −0.2^\*^                      **−0.**5^\*^   −0.1       −0.4^\*^       0.0           **−0.**5^\*^   −0.2^\*^      −0.2^\*^      0.3^\*^    −0.2^\*^   ** −0.**5^\*^                 
  Shape (r)   −0.1                            0.0                    −0.1                          −0.1           0.0        0.0            0.0           −0.1           0.0           0.0           0.1        0.0         −0.1           0.1           
  Texture     −0.4^\*^                        −0.4^\*^               −0.4^\*^                      **−0.**7^\*^   −0.3^\*^   **−0.**6^\*^   −0.1          **−0.**7^\*^   −0.2^\*^      −0.3^\*^      0.4^\*^    −0.3^\*^   ** −0.**6^\*^   **0.**5^\*^   0.1

Abbreviations: FL, frontal lobe; OL, occipital lobe; PL, parietal lobe; TL, temporal lobe; CC, cingulate cortex; AM, amygdala; CN, caudate nucleus; HI, hippocampus; PA, pallidum; PU, putamen; VE, ventricular; WB, whole brain.
